ABBOTT LABORATORIES — Director's Dealing 2020

Mar 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2020-02-28

Reporting Person: Funck Robert E (Executive Vice President & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-28	Common shares without par value	F	6710	$79.19	Disposed	170728	Direct
2020-03-02	Common shares without par value	S	1356	$77.89	Disposed	169372	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	17570	Indirect
Common shares without par value	500	Indirect
Common shares without par value	500	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2020.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.